CStone Pharmaceuticals (CSPHF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -588.84 Million | -612.46 Million | -1.48 Billion | -508.07 Million | -1.08 Billion | -791.1 Million |
| Net Income | -367.23 Million | -902.67 Million | -1.92 Billion | -1.22 Billion | -2.3 Billion | -1.79 Billion |
| Depreciation & Amortization | 58.19 Million | 44.54 Million | 22.66 Million | 14.8 Million | 11.58 Million | 5.26 Million |
| Deferred income taxes | - | 32.6 Million | 134.23 Million | 179.41 Million | 637.36 Million | 741.97 Million |
| Stock-based compensation | 36.99 Million | 142.06 Million | 222.67 Million | 356.02 Million | 410.71 Million | 234.96 Million |
| Change in working capital | -140.81 Million | 72.64 Million | 64.52 Million | 185.97 Million | 235.83 Million | 27.87 Million |
| Other non-cash items | -21.31 Million | -1.64 Million | -8.01 Million | -23.29 Million | -67.77 Million | -8.06 Million |
| Investing Cash Flow | 619.6 Million | 365.11 Million | -826.55 Million | 1.18 Billion | -658.88 Million | -377.7 Million |
| Investments in PPE | -65.04 Million | -101.82 Million | -149.13 Million | -71.44 Million | -10.42 Million | -7.9 Million |
| Acquisitions | - | 101.82 Million | -48.41 Million | 18.45 Million | 38.51 Million | 4.27 Million |
| Investment purchases | -67.77 Million | -683.4 Million | -1.05 Billion | -358.87 Million | -1.6 Billion | -1.04 Billion |
| Sales/Maturities of investments | 515.47 Million | 1.14 Billion | 363.53 Million | 1.59 Billion | 919.32 Million | 664.66 Million |
| Other Investing Activities | 619.62 Million | -98.68 Million | 58.48 Million | 671 Thousand | -961 Thousand | 4.33 Million |
| Financing Cash Flow | 388.35 Million | 28.46 Million | 92.3 Million | 1.38 Billion | 2.09 Billion | 1.66 Billion |
| Debt repayment | -91.43 Million | -32 Million | -6.7 Million | -1.58 Million | -4.68 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -21.8 Million | - | - |
| Common Stock Issuance | 341.82 Million | 2.52 Million | 16.83 Million | 1.36 Billion | 2.19 Billion | 3.62 Million |
| Other Financing Activities | 328.33 Million | 57.93 Million | 82.18 Million | 51.88 Million | -106.18 Million | 1.66 Billion |
| Accounts receivables | -95.3 Million | 40.46 Million | -117.59 Million | - | - | - |
| Accounts payables | - | -40.46 Million | 117.59 Million | - | - | - |
| Inventory | -95.46 Million | 30.41 Million | -61.36 Million | - | - | - |
| Other working capital | 104.92 Million | 42.22 Million | 125.88 Million | 185.97 Million | 235.83 Million | -40.18 Million |
| Cash at beginning of period | 558.68 Million | 742.72 Million | 3.02 Billion | 1.12 Billion | 701.33 Million | 83.39 Million |
| Cash at end of period | 996.67 Million | 558.68 Million | 742.72 Million | 3.02 Billion | 1.12 Billion | 701.33 Million |
| Capital Expenditure | -65.04 Million | -101.82 Million | -149.13 Million | -71.44 Million | -10.42 Million | -7.9 Million |
| Effect of forex changes on cash | 18.87 Million | 34.84 Million | -63.55 Million | -163.97 Million | 73.37 Million | 124.33 Million |
| Net cash flow / Change in cash | 437.98 Million | -184.04 Million | -2.28 Billion | 1.89 Billion | 425.1 Million | 617.94 Million |
| Free Cash Flow | -653.89 Million | -714.29 Million | -1.63 Billion | -579.51 Million | -1.09 Billion | -799.01 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -367.23 Million | -21.85 Million | -30.18 Million | -77.72 Million | -902.67 Million | -55.62 Million |
| Depreciation & Amortization | 58.19 Million | 4.08 Million | 4.13 Million | 4.12 Million | 44.54 Million | 4.03 Million |
| Deferred income taxes | - | - | - | - | 32.6 Million | - |
| Stock-based compensation | 36.99 Million | - | - | - | 142.06 Million | - |
| Change in working capital | -140.81 Million | 3.47 Million | -22.87 Million | 40.54 Million | 72.64 Million | -29.97 Million |
| Other non-cash items | -21.31 Million | -16.07 Million | 44.37 Million | -6.18 Million | -1.64 Million | 41.01 Million |
| Investing Cash Flow | 619.6 Million | 27.5 Million | 55.19 Million | -15.5 Million | 365.11 Million | 66.24 Million |
| Investments in PPE | -65.04 Million | -8.99 Million | - | -3.32 Million | -101.82 Million | -11.24 Million |
| Acquisitions | - | 29.97 Million | - | 1.00 | 101.82 Million | - |
| Investment purchases | -67.77 Million | -76.67 Thousand | -9.26 Million | -98.16 Million | -683.4 Million | - |
| Sales/Maturities of investments | 515.47 Million | 6.58 Million | 64.44 Million | 85.92 Million | 1.14 Billion | 78.46 Million |
| Other Investing Activities | 619.62 Million | 21.3 Thousand | 12.11 Thousand | 63.34 Thousand | -98.68 Million | -983.8 Thousand |
| Financing Cash Flow | 388.35 Million | 15.8 Million | 39.17 Million | 7.49 Million | 28.46 Million | -1.7 Million |
| Debt repayment | -91.43 Million | -20.5 Million | -7.83 Million | -10.66 Million | -32 Million | -971.64 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 341.82 Million | -2.15 Million | 48.8 Million | 259.69 Thousand | 2.52 Million | 103.07 Thousand |
| Other Financing Activities | 328.33 Million | - | -1.79 Million | -3.42 Million | 57.93 Million | - |
| Accounts receivables | -95.3 Million | 17.11 Million | -15.68 Million | 11.31 Million | 40.46 Million | -7.14 Million |
| Accounts payables | - | 2.66 Million | -19.41 Million | 13.04 Million | -40.46 Million | -13.42 Million |
| Inventory | -95.46 Million | -13.32 Million | 118.45 Thousand | 4.12 Million | 30.41 Million | 245.21 Thousand |
| Other working capital | 104.92 Million | -2.97 Million | 12.11 Million | 12.06 Million | 42.22 Million | -9.64 Million |
| Cash at beginning of period | 558.68 Million | 124.71 Million | 80.29 Million | 109.23 Million | 742.72 Million | 116.5 Million |
| Cash at end of period | 996.67 Million | 140.49 Million | 124.71 Million | 80.29 Million | 558.68 Million | 109.23 Million |
| Capital Expenditure | -65.04 Million | -8.99 Million | - | -3.32 Million | -101.82 Million | -11.24 Million |
| Effect of forex changes on cash | 18.87 Million | - | -2.14 Million | -1.92 Million | 34.84 Million | -2.86 Million |
| Net cash flow / Change in cash | 437.98 Million | 15.77 Million | 44.42 Million | -28.93 Million | -184.04 Million | -7.27 Million |
| Free Cash Flow | -653.89 Million | -41.07 Million | -47.8 Million | -22.33 Million | -714.29 Million | -80.18 Million |
1050
5842
CAH
KAL
GBCI
TPTW